AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2013
Mar 12, 2013
29755_dirs_2013-03-12_c8a37d76-e7d3-4541-bdd1-3c06d0a42cda.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-03-08
Reporting Person: LEONARD JOHN M. (SVP, Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-03-08 | Common stock, $0.01 par value | S | 4305 | $37.58 | Disposed | 130964 | Direct |
| 2013-03-08 | Common stock, $0.01 par value | S | 23644 | $37.50 | Disposed | 107320 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 6473 | Indirect |
Footnotes
F1: Balance in the AbbVie Savings Program as of March 8, 2013.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4